Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4282 USD | +5.34% | -7.91% | -2.66% |
Sales 2024 * | - | Sales 2025 * | 2.57M 214M | Capitalization | 21.37M 1.78B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.25B | Net income 2025 * | -28M -2.33B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.31 x |
P/E ratio 2024 * |
-0.79
x | P/E ratio 2025 * |
-0.91
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.01% |
Latest transcript on AIM ImmunoTech Inc.
1 day | +5.34% | ||
1 week | -7.91% | ||
Current month | -9.09% | ||
1 month | -3.34% | ||
3 months | +6.25% | ||
6 months | -0.42% | ||
Current year | -2.66% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 17/08/17 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 04/22/04 |
Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 28/23/28 |
William Mitchell
CHM | Chairman | 89 | 01/98/01 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 17/08/17 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.4282 | +5.34% | 85,255 |
25/24/25 | 0.4065 | -5.47% | 341,694 |
24/24/24 | 0.43 | +1.06% | 160,867 |
23/24/23 | 0.4255 | +1.31% | 256,717 |
22/24/22 | 0.42 | -9.68% | 169,268 |
Delayed Quote Nyse, April 27, 2024 at 01:40 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.66% | 21.37M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AIM Stock